Flu shot yields mixed findings in HF, with some seasonal CV benefit

WASHINGTON — People with HF who received an annual influenza vaccine had a reduction in major CV events during peak influenza season and lower rates of hospitalization and pneumonia on a year-round basis, according to the IVVE study.
IVVE was a randomized controlled trial of an influenza vaccine to prevent adverse CV events in 5,000 participants with HF who received a vaccine or placebo over three influenza seasons. The global trial, which was conducted in 10 countries across Africa, Asia and the Middle East, did not meet its co-primary endpoints, which were focused on major adverse CV

WASHINGTON — People with HF who received an annual influenza vaccine had a reduction in major CV events during peak influenza season and lower rates of hospitalization and pneumonia on a year-round basis, according to the IVVE study.
IVVE was a randomized controlled trial of an influenza vaccine to prevent adverse CV events in 5,000 participants with HF who received a vaccine or placebo over three influenza seasons. The global trial, which was conducted in 10 countries across Africa, Asia and the Middle East, did not meet its co-primary endpoints, which were focused on major adverse CV